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Abstract
The peak in influenza incidence during wintertime in temperate regions represents a longstanding, unresolved scientific
question. One hypothesis is that the efficacy of airborne transmission via aerosols is increased at lower humidities and
temperatures, conditions that prevail in wintertime. Recent work with a guinea pig model by Lowen et al. indicated that
humidity and temperature do modulate airborne influenza virus transmission, and several investigators have interpreted the
observed humidity dependence in terms of airborne virus survivability. This interpretation, however, neglects two key
observations: the effect of ambient temperature on the viral growth kinetics within the animals, and the strong influence of
the background airflow on transmission. Here we provide a comprehensive theoretical framework for assessing the
probability of disease transmission via expiratory aerosols between test animals in laboratory conditions. The spread of
aerosols emitted from an infected animal is modeled using dispersion theory for a homogeneous turbulent airflow. The
concentration and size distribution of the evaporating droplets in the resulting ‘‘Gaussian breath plume’’ are calculated as
functions of position, humidity, and temperature. The overall transmission probability is modeled with a combination of the
time-dependent viral concentration in the infected animal and the probability of droplet inhalation by the exposed animal
downstream. We demonstrate that the breath plume model is broadly consistent with the results of Lowen et al., without
invoking airborne virus survivability. The results also suggest that, at least for guinea pigs, variation in viral kinetics within
the infected animals is the dominant factor explaining the increased transmission probability observed at lower
temperatures.
Citation: Halloran SK, Wexler AS, Ristenpart WD (2012) A Comprehensive Breath Plume Model for Disease Transmission via Expiratory Aerosols. PLoS ONE 7(5):
e37088. doi:10.1371/journal.pone.0037088
Editor: Steven J. Drews, University of Calgary & ProvLab Alberta, Canada
Received October 12, 2011; Accepted April 17, 2012; Published May 15, 2012
Copyright:  2012 Halloran et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: No current external funding sources for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: wdristenpart@ucdavis.edu
Introduction
Influenza virus transmission rates display a strong peak during
wintertime in temperate regions but less defined seasonality in
tropical regions, suggesting that environmental factors drive
seasonal variations [1,2]. The exact nature of the underlying
environmental factors, however, is unclear. One longstanding
hypothesis is that the lower temperatures and lower humidities
prevalent in wintertime somehow enhance influenza virus
transmission. Recent work by Lowen et al. with a guinea pig
model [3] provided direct evidence that temperature and humidity
do modulate airborne influenza transmission [4–6]. They dem-
onstrated that the probability of transmission at low temperatures
(5uC) ranged from 100% at low relative humidities to 50% at
higher relative humidities. There was more variability at
intermediate temperatures, and notably, there was 0% probability
of transmission at 30uC regardless of humidity. Lowen et al.
concluded that both temperature and relative humidity affect
influenza virus transmission, but no clear mechanism was
identified.
More recently, Shaman and Kohn reexamined the data
reported by Lowen et al. and demonstrated that the transmission
probability was even more strongly correlated with the absolute
humidity (i.e., the ambient water vapor pressure) than with the
relative humidity [7]. Since the rate of evaporation of airborne
droplets depends on the absolute humidity of the air, not the
relative humidity, they examined the hypothesis that the
probability of transmission was governed by an ‘‘aerosol persis-
tence’’ mechanism. The key idea in this model, which dates back
to the pioneering work by Wells and Riley [8,9], is that larger
drops sediment by gravity out of the air more quickly than smaller
drops [10,11]. Accordingly, conditions which favor rapid evapo-
ration (i.e., low absolute humidity) favor the persistence of the
droplets in the air and increase the probability of transmission.
When comparing Lowen et al.’s data against a model predicated
on a competition between evaporation and gravitational sedimen-
tation, however, Shaman and Kohn found no correlation [7].
They concluded that aerosol persistence was not responsible for
the observed dependence on absolute humidity, and instead they
focused on the effect of humidity on virus survivability. Upon
reanalyzing a different set of measurements of airborne virus
survivability [12], Shaman and Kohn revealed a pronounced
correlation between the 1-hour survivability and the absolute
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humidity. Because of this observation, much subsequent effort has
focused on considering the role of airborne virus survivability in
explaining epidemiological trends [13–17].
There are several pieces of evidence, however, suggesting that
virus survivability was not the primary mechanism underlying the
transmission behavior observed by Lowen et al. First, it is unclear
that gravity was the dominant force affecting the motion of the
airborne droplets in their experiments. Lowen et al. initially
focused on establishing that infection occurs between guinea pigs
solely by airborne transmission, and they verified that transmission
occurs at separation distances between animals up to almost
100 cm away. Crucially, however, they also noted that ‘‘…trans-
mission was not observed when the relative positions of the
infected and uninfected animals were reversed, suggesting that
spread depended on the direction of airflow in the room.’’ [3] In
other words, there was a direct correlation between the direction
of airflow and transmission. Subsequent experiments demonstrat-
ed the role of airflow even more convincingly, by placing the test
animals 100 cm above the infected animals, with the airflow
directed upward [6]. Disease transmission indeed occurred,
obviating any attempt to invoke gravity as the dominant force
affecting the motion of pathogen-laden droplets.
A second crucial consideration is that Lowen et al. observed a
pronounced difference in the viral growth kinetics between
animals kept at 5uC and 30uC. Following inoculation, viral
concentrations typically increase exponentially during the viral
growth period and then decay exponentially as the immune system
destroys the virus [18]. The viral concentrations in the guinea pigs
tested by Lowen et al. followed this pattern, but the animals kept at
5uC exhibited a substantial lag time in the exponential decay.
Specifically, the viral concentration in animals kept at 5uC was on
average two orders of magnitude larger, for several days, when
compared to animals kept at 30uC. Despite the clear difference in
the viral growth kinetics within the infected animals, to date no
analyses have elucidated the temperature dependence of growth
kinetics on the probability of airborne transmission. Given that
airborne transmissibility is believed to govern the potential for
specific viral strains to spark pandemics [19,20], a fundamental
understanding of both the physics and biology underlying
laboratory airborne transmission experiments is imperative.
In this article we present a comprehensive theoretical frame-
work for assessing the probability of disease transmission via
expiratory aerosol droplets between animals placed in a controlled
airflow, i.e., a constant background airflow of known direction and
velocity. The physics and biology of all five stages of transmission –
the pathogen source, transport, transformation during transport,
deposition, and infection – are explicitly considered (Figure 1 top).
The model yields three important testable hypotheses:
1) The transmission probability will decrease as the airflow
velocity increases.
2) The transmission probability will decrease as the degree of
turbulence increases.
3) The transmission probability will increase with the time integral
of the pathogen concentration within the inoculated animal.
We focus here on influenza virus transmission under experi-
mental conditions similar to those used by Lowen et al., although
the theoretical framework is applicable to other airborne diseases.
A key implication of the model is that temperature-dependent
variation in viral growth kinetics within the infected animals,
rather than airborne viral survivability, is the dominant factor
underlying increased influenza transmission observed experimen-
tally at lower temperatures.
Methods
Breath Plume Model
We consider animals placed in individual cages inside an
environmental chamber, oriented such that the test animal is
placed downstream from the inoculated animal in a horizontal
airflow of mean velocity U and fixed temperature and humidity
(Figure 1 bottom). Although the animals are typically free to move
around within their cages, we assume that any fluctuations in
position are negligible compared to the distance between animals
and that, on average, the test animal occupies a fixed location x.
The main goal here is to obtain an estimate for the number of
pathogens inhaled by the downstream test animal, which
necessitates consideration of each of the five stages of transmission
(cf. Figure 1 top).
Pathogen Source
When considering airborne transmission, the first question to
ask is: how many pathogens are exhaled by the inoculated animal?
This quantity is difficult to measure directly, so instead we obtain
insight from consideration of the measured viral concentrations
within the animal (typically from nasal titers). Viral infections
normally exhibit exponential growth as infected cells produce
virus, followed by exponential decay as the immune system
deactivates the virus [18]. In the experiments by Lowen et al., the
guinea pigs were intranasally inoculated at t = 0, but the test
animals were not placed inside the environmental chamber until
t = 24 hr; the animals remained within the test chamber for the
next seven days.
The viral titers obtained via nasal washes by Lowen et al. [4,5]
are plotted in Figure 2 for animals kept at 5uC and 30uC.
Qualitatively, the viral concentrations follow the expected
behavior, with an initial rapid increase followed by exponential
decay. The measured peak viral concentrations were of similar
Figure 1. Transmission model and definition sketch. Top,
transmission model diagram. Bottom, definition sketch for airborne
transmission between animals in a controlled airflow (not to scale). The
homogeneous turbulent flow moves left-to-right with average velocity
U, turbulent dispersivity (sy, sz), and fixed humidity and temperature.
An infected animal at x, y = 0 exhales droplets with pathogen
concentration np
drop(t) at a rate q. The drops evaporate to size amin,
and disperse via turbulent diffusion to concentration Cdrop. The
pathogen-laden droplets are potentially inhaled by a test animal
downstream that is breathing at rate B with deposition efficiency g(a).
doi:10.1371/journal.pone.0037088.g001
Breath Plume Model for Disease Transmission
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magnitude, but the dynamics are strikingly different: the viral titers
of animals kept at 5uC were consistently larger, by about two
orders of magnitude, for days 4 through 8. The reason for this
difference is unclear; Lowen et al. demonstrated that the colder
ambient temperature had no measurable effect on the innate
immune response of the animals, and they hypothesized that
inhalation of colder air somehow favored growth in the mucosa of
the guinea pigs [4]. Regardless of the biological mechanism, it is
clear that the test animals at the colder ambient temperature were
exposed to higher concentrations of virus for a significantly longer
time period.
To capture this difference in viral kinetics, we fit Lowen et al.’s
experimental measurements to a standard model [18] of viral
growth (dashed lines, Figure 2). As discussed by Baccam et al. [18],
experimental measurements of viral concentrations can be fit to a
numerical model that tracks the number of healthy or infected
target cells (Text S1, Table S2). The viral concentration curves fit
using this model make clear that the exponential growth period
takes considerably longer and reaches a higher peak concentration
at 5uC than at 30uC. A similar observation pertains at 20uC
(Figure S1A).
Because both the growth and decay periods are linear on a
logarithmic scale [21], a convenient analytical expression may be
used to estimate the viral concentrations during the growth and
decay, viz.
ndropp tð Þ~
n
drop
p0 10
kgt
 
, 0vtƒtpeak
ndrop,maxp 10
{kd t{tpeak
 " #
, twtpeak
8><
>: ð1Þ
Here, np0
drop is the initial pathogen concentration in the droplet,
np
drop, max is the maximum observed concentration in the droplet
occurring at time tpeak, and kg and kd are the rate constants for the
growth and decay periods, respectively. This approach underes-
timates the numerical solution but allows a purely analytical
estimate of the transmission probability (solid lines, Figure 2).
The above discussion focuses on the nasal titers, but the real
quantity of interest for airborne transmission is the concentration
of pathogens within exhaled droplets. As discussed in detail by
Johnson et al., these droplets are most likely formed within the
bronchioles via a ‘‘film rupture’’ mechanism [22]. It is well known
that viral concentrations within the lungs and the nose can differ
substantially; for example, a recent study of influenza viral growth
in guinea pig respiratory tracts by Tang et al. showed that viral
titers varied substantially between the nose, trachea, and lungs,
with the nasal titers consistently highest for guinea pigs infected
with strains of both H3N2 and H1N1 [23]. Although the absolute
concentrations differ, a key observation is that for some strains, the
viral titers of the different regions rise and fall in tandem.
Accordingly, we assume that the pathogen concentration within
any given expiratory droplet (np
drop) is determined by the pathogen
concentration within the bronchial respiratory fluid (np
bronchial) at
the time of expiration, which in turn is proportional to the known
pathogen concentration within the nasal mucosa (np
nasal), viz.
ndropp ~n
bronchial
p ~xn
nasal
p ð2Þ
Here x is defined simply as the ratio of the bronchial and nasal
pathogen concentrations, which in general could differ for
different strains of the same virus. We emphasize that a more
direct approach would be to use experimentally measured
bronchial pathogen concentrations, but such measurements are
non-trivial; in the absence of that information we instead use the
above approach based on the nasal titer and a proportionality
factor to provide an estimate.
The infected animal is assumed to exhale q droplets per unit
time, and as a first approximation we assume that q is invariant
throughout the experiment. The number of pathogens or
‘payload’ in any given droplet is np
drop(t)VO, where VO = 4/3paO
3
is the initial volume of each droplet upon exhalation. Although the
droplet can change size (as discussed below), the pathogens
themselves are assumed to be nonvolatile. Accordingly, the
number of pathogens in any given drop does not change following
exhalation; the time between droplet exhalation by the infected
guinea pig and inhalation by the naı¨ve animal downstream is brief,
so the pathogens are assumed not to multiply or deactivate during
this time period (see Transformation). The concentration of
pathogens per unit volume of air at any given location is
Cpath(x,t)~Cdrop(x)n
drop
p (t)V0 ð3Þ
where Cdrop (x) is the local concentration of expiratory droplets per
unit volume of air.
Transport
With an estimate of the pathogen generation in hand, the next
question is: how do the pathogen laden droplets move from the
inoculated animal to the test animal? Traditionally the concen-
tration Cdrop of airborne pathogen-laden droplets has been assumed
to be spatially invariant in the surrounding air, i.e., the air in a
room is assumed to be well mixed [7–9,11]. Here, however, we are
interested in the probability of transmission within airflow
occurring in a prescribed direction (cf. Figure 1 bottom). In other
words, the air is not well-mixed and the concentration depends
sensitively on the location x of the test animal with respect to the
Figure 2. Guinea pig viral growth kinetics at different
temperatures. The measurements by Lowen et al. [4,5] of the
influenza concentration observed in nasal titers obtained from
inoculated guinea pigs maintained at different temperatures. Blue
circles: T = 5uC; red squares: T = 30uC. Dashed lines are fits to a numerical
model for influenza viral dynamics [18]; solid lines are analytical
estimates given by Equation 1.
doi:10.1371/journal.pone.0037088.g002
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infected animal. Notably, the guinea pigs used by Lowen et al. did
not sneeze or cough [3], so here we need not consider the
contribution of high-velocity jets due to sneezing and/or coughing
on the droplet transport [10,24]. Instead, we restrict attention to
situations where the normal exhalation velocity is small compared
to the background airflow; in this limit, the droplets are simply
carried along by the background airflow following expiration.
The airflow in typical environmental chambers is turbulent, so
upon exhalation the droplets do not simply move in a straight line;
the turbulent eddies work to disperse the droplets in directions
orthogonal to the mean flow direction. Moreover, if the drops are
sufficiently small and the airflow magnitude sufficiently large, then
the influence of gravity may be neglected (Text S2). Two
archetypal problems have been examined for the case of
particulates released from a point source in a uniform turbulent
airflow: the ‘puff’ model, in which particulates are released at a
discrete point in time, and the ‘plume’ model, in which particulates
are released continuously [25]. We are interested here in aerosols
released by exhalation in discrete ‘puffs’ from a test animal, so the
concentration distribution results from the superposition of
multiple puffs. If we restrict attention to time scales much longer
than the breathing rate, however, then the periodic variations in
the concentration are averaged out and the concentration of
droplets within the ‘plume’ is invariant with time. Since the typical
breathing frequency is 1 Hz and the typical experiment takes
several days, this constraint is readily satisfied.
Accordingly, we invoke the ‘slender Gaussian plume’ model
[25] for a point source in a homogenous turbulent flow oriented in
the x-direction,
Cdrop(x,y,z)~
q
2pUsysz
exp
{y2
2sy2
 
exp
{(z{h)2
2sz2
 !
{exp
{(zzh)2
2sz2
 !" # ð4Þ
Here h is the vertical distance (in the z-direction) from the floor to
the point source, and the parameters sy(x) and sz(x) are the root
mean square (rms) displacements in the y and z directions,
respectively. In choosing Equation 4, several assumptions have
been made. First, we assume that the plume is sufficiently slender
such that mean concentration gradients along x are negligible
compared to those along y and z, and consequently turbulent
dispersion is negligible in the flow direction; this assumption is
consistent with the idea that the aerosol displacement is dominated
by a large airflow velocity U. Second, we assume all droplets
impacting the floor are absorbed perfectly such that no droplets
‘bounce’ back into the airflow. Moreover, these impacted droplets
are assumed to be non-infective. Finally, we assume that all other
solid surfaces (e.g., ceiling, walls) are sufficiently far away that the
viral plume is not affected by them; in other words, this approach
will be valid provided that the width of the plume is small
compared to the dimensions of the chamber.
Similar Gaussian plume models have been considered in the
context of airborne disease transmission in outdoor environments,
but applications are limited because the model does not account
for topographical features, inhomogeneous turbulence, or fluctu-
ations in ambient weather conditions [26,27]. In contrast, the
conditions in a laboratory environment allow greater control over
the airflow. Although sy and sz have not generally been measured
for lab-scale environmental chambers with caged animals,
experimental work in the context of atmospheric science provides
insight on the expected behavior. We assume that the airflow is
sufficiently turbulent such that the contribution from molecular
diffusivity is negligible, and we restrict attention to short distances
sufficiently close to the point source such that the dispersion
coefficients grow linearly with distance, viz.,
sy~iyx, sz~izx ð5Þ
Here iy = uy/U and iz = uz/U, where uy and uz are the rms turbulent
velocities in the y and z directions. These velocities characterize
‘how turbulent’ the flow is and are typically a few percent of the
mean velocity [28]. Larger values mean that more material is
transported in the orthogonal directions, so concentrations along
the center line (y= 0, z= 0, x.0) are reduced.
Transformation
Next, we ask the question: how do the expired droplets change
while they are transported? Following expiration and prior to
inhalation by the test animal, the drops and/or the pathogens
within them are in general susceptible to changes induced by the
ambient conditions. Specifically, the drops may shrink by
evaporation, and the pathogens within the drops might become
deactivated. Again focusing on the experimental conditions used
by Lowen et al., we note that the typical airflow velocity in their
environmental chamber is 10 cm/s, which means that only ten
seconds transpire before the drops pass a test animal 1 m away.
Notably, Harper et al. did not make any virus survivability
measurements shorter than five minutes [12]; similarly, Hemmes et
al. reported no survivability measurements shorter than at least
two minutes [29]. There is no evidence that virus survivability
varies measurably on the time scale of tens of seconds.
Accordingly, issues of virus survivability are assumed to not apply
on the short time scales of interest here. In other words, the
absolute number of pathogens in any given droplet is assumed to
remain constant during transport; neither any viral replication nor
deactivation occur.
In contrast, the size of the droplets is highly sensitive to the
ambient temperature and humidity. The droplet size is a concern
here not because of gravitational effects (which are neglected), but
because droplet inhalation and deposition are highly sensitive to
the droplet size (see below). There are many models of droplet
evaporation of varying complexity, but here we use the well-
known R2 model, so named because the evaporation rate depends
on the square of the drop radius. Also used by Shaman and Kohn
to estimate the evaporation time [7], the R2 model strictly applies
to one-component droplets undergoing pseudo-steady evapora-
tion. However, experimental work by Ranz et al. suggests that the
R2 model works well even for droplets with large concentrations of
proteins or other solutes, until the droplets shrink to a critical size
amin governed by the amount of nonvolatile solute present [30,31].
This minimum size is given as amin = ja0, where j;(Cnv/rnv)1/3 is
the ratio of the concentration to density of nonvolatile species in
the droplet [32]. The resulting ‘droplet nucleus’ of size amin will
continue to be carried along with the flow. Accordingly, following
the standard evaporation analysis [7], droplets shrink with time as
a teð Þ~ a0
ffiffiffiffiffiffiffiffiffiffiffiffiffi
1{bte
p
, 0vteƒtcrit
amin, tewtcrit
(
ð6Þ
Here te is time elapsed since expiration of a droplet with initial
radius a0, and b
21 is a characteristic time scale given by
Breath Plume Model for Disease Transmission
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b:
2D Psat{P?ð Þ
a20rRvT ð7Þ
where D is the molecular diffusivity of water vapor, r is the density
of liquid water, Rv is the specific gas constant for water, P‘ is the
ambient partial pressure of water (i.e., the absolute humidity) and
Psat is the saturation water vapor pressure at the droplet surface.
Several features of this model are noteworthy. First, larger values
of b correspond to shorter evaporation time scales, i.e., the droplet
reaches its minimum size more quickly (Figure 3A). As pointed out
by Shaman and Kohn, the same relative humidity yields very
different evaporation rates at different temperatures. Secondly, the
time scale for the droplet to cool down to its final temperature is
sufficiently short compared to the time scale for evaporation, so
this is regarded as an isothermal process. Also, since we are
restricting attention to conditions where the background airflow is
invariant in time, and since the droplets are assumed to travel
steadily in the x-direction at the same velocity as the airflow, the
elapsed time since expiration and droplet position are inter-
changeable, i.e., te = x/U.
Deposition
The next key question is: how many droplets are actually
inhaled by the test animal? The breathing rates of the infected test
animals will vary over the course of a multi-day experiment, due to
natural cycles of activity and sleep. As a first approximation,
however, we ignore this complexity and assume that B, the animal
breathing rate, is constant throughout the experiment. Inhalation
of the droplet-laden air, however, does not necessarily mean
pathogen deposition will occur. The efficiency of deposition is
highly sensitive to the droplet size and varies as a function of
position throughout the respiratory system [33]. Previous work
with airborne transmission has indicated that infections via
aerosols are most likely to originate in the lower respiratory tract,
specifically the alveoli [32]. In the case of influenza, however,
experiments by Lowen et al. [3] and Tang et al. [23] have shown
that infection occurs in both the upper and lower respiratory tract.
Both groups investigated regional viral growth kinetics following
intranasal inoculation, but to our knowledge, similar experiments
have not been conducted in guinea pigs in the context of natural
airborne transmission. Because the site of airborne infection is not
absolutely clear, we consider here deposition in both the
nasopharyngeal-tracheobronchial region (NPTB) and the pulmo-
nary (i.e., alveolar) regions. Typical NPTB and pulmonary
deposition efficiency profiles for guinea pigs are plotted versus
droplet size in Figure 3B using the model developed by Schreider
et al. [34,35].
Note that the deposition efficiency, g(a), involves three key
mechanisms: inertial impaction, diffusion, and sedimentation.
Figure 3B illustrates that the largest and smallest particles are most
likely to deposit in the NPTB region, but by different mechanisms.
The increased size of large particles leads to their deposition
directly via impaction. In contrast, the motion of small particles is
dominated by diffusion; smaller particles diffuse more quickly and
are more likely to collide with a surface in the NPTB region and
subsequently deposit. Intermediate sized particles are most
successful at traversing the airway and depositing in the depths
of the lung, i.e., in the alveolar region [34,35].
The total number of pathogens ultimately deposited in the
respiratory system of a test animal during a time interval dt is
related to the local airborne concentration of pathogens as
dm~Cpath(x,t)g að ÞBdt ð8Þ
Combination of Equation 8 with Equations 1 and 3 and
integration with respect to time yields the expected number of
deposited pathogens,
m~
Cdrop(x)V0g að ÞB
ln 10ð Þ
	 

:
n
drop
p0 ð10kgtpeak{10kgtdel

kg
z
ndrop,maxp 1{10
kd tpeak{ ttotztdelð Þ
  !
kd
2
66664
3
77775
ð9Þ
where tdel is the delay time between inoculation and the start of the
transmission experiments and ttot is the total time of exposure. This
equation is valid for tdel,tpeak,ttot+tdel, ensuring the onset of the
decay phase occurs during the experiment. As discussed previous-
ly, Equation 1 provides an underestimate of the actual pathogen
concentration; a more accurate value may be obtained either by
integration of the numerical model (cf. dashed lines in Figure 2) or
direct numerical quadrature of the experimental measurements.
For situations where there is a distribution of initial droplet sizes
(as is likely to be encountered experimentally), the total expected
value m is simply the sum of the expected values resulting for each
size.
Infection
Finally, we relate the overall probability of transmission to the
total number of deposited pathogens in the test animal. We assume
that all of the naı¨ve animals in a given experiment are equally
susceptible to infection, a condition likely to pertain to genetically
similar animals with equivalent health histories. Following the
standard approach [32,36], we assume that the risk of transmission
is given by the Poisson probability that the number of deposited
pathogens m in the test animal exceeds the number n of pathogens
required to initiate infection, i.e.,
Figure 3. Droplet size evolution and deposition efficiencies. (A)
Aerosol size versus time for droplets in air at 50% RH. Solid lines,
a0= 5 mm; dotted lines, a0= 15 mm. Blue curves: T = 5uC; red curves:
T = 30uC. (B) The deposition efficiency of a unit-density particle of radius
a depositing in the pulmonary (P) and nasopharyngeal-tracheobron-
chial (NPTB) regions of a guinea pig. Purple: Pulmonary; black: NPTB.
Reproduced from Schreider et al. [34,35].
doi:10.1371/journal.pone.0037088.g003
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Ptrans~1{
Xn{1
j~0
mje{m
j!
ð10Þ
The summation term on the right-hand side represents the
probability that fewer than n pathogens deposit. To our
knowledge, the minimum infectious dose for guinea pigs is not
well characterized, but prior studies have shown that the infectious
dose for aerosol transmission in humans is very small [37]. Note
that viral titer measurements are typically reported in units of pfu/
mL, and it has been previously shown that 1 TCID50/mL, and
subsequently 1 pfu/mL, likely contains a large number of
influenza virions [38,39]. Accordingly, we assume here that
deposition of at least one plaque-forming unit (n= 1) can initiate
infection, in which case Equation 10 simplifies to
Ptrans~1{e
{m ð11Þ
Results and Discussion
Comparison with Experiments
To compare the model with the experimental observations,
several parameters require specification. Wherever possible, we
used the experimental values reported by Lowen et al. To our
knowledge, however, the rate q and size distribution of expiratory
droplets have not been measured for guinea pigs. As an
approximation, we instead used measurements from a recent
characterization of expiratory droplets released by ferrets intra-
nasally inoculated with influenza [40]. Likewise, the minimum
droplet size amin was estimated using an exhaled breath condensate
study conducted by Effros et al. [41], who determined the protein
and salt concentrations in healthy human respiratory fluid. As for
the background airflow, Lowen et al. did not report the velocity,
but air speed was estimated using known values for flow velocity
entering and exiting the Caron Model 6030 environmental
chamber. The turbulent dispersivities (cf. Equation 5) were
estimated by assuming that the stability class was ‘near neutral’,
a condition likely to pertain in controlled laboratory situations
[28]. A full list of model parameters is provided in Table S1.
Representative contour plots of the transmission probability as a
function of downstream position, as calculated by Equation 11, are
presented in Figure 4 for different temperatures and humidities for
both the pulmonary and NPTB deposition efficiencies. In each
case there is a high probability of transmission near the inoculated
animal (i.e., near x, y= 0, 0), with the probability decaying toward
zero at larger distances. The exact shape of the ‘infectious zone’,
however, depends sensitively on the ambient temperature for both
deposition efficiencies (Figure 4A, B, C, G, H, I): at 5uC the
infectious zone extends nearly five times as far as at 30uC. The
effect of humidity is more subtle. There is no significant difference
between 5% and 60% relative humidity at 5uC (Figure 4D, E, J,
K), but at sufficiently high humidity, the size of the infectious zone
decreases appreciably for the pulmonary deposition model
(Figure 4F). At high humidity, the infectious zone is essentially
the same size as at lower humidities for the NPTB deposition
efficiency, but there is a slight increase in probability of infection
very close to the inoculated guinea pig (Figure 4L). We emphasize
that the temperature here affects only the viral growth kinetics
within the infected animals (cf. Figure 2) and the rate of droplet
evaporation (cf. Figure 3A), while the humidity only affects the rate
of evaporation. The probability contours presented in Figure 4 can
thus be interpreted in terms of how the temperature and humidity
affect the ‘payload’ of pathogens delivered to the test animal. The
range of infection is increased at low temperatures primarily due to
the longer time period of increased viral concentrations emitted by
the animal; the growth period is extended and the peak viral titer is
higher, so more pathogen is released. At the higher temperatures,
in contrast, the viral concentrations in the animal decay more
rapidly and have a lower peak value so less pathogen is
transmitted, decreasing the probability of transmission.
The pathogen payload also depends sensitively on the droplet
size upon inhalation by the test animal. A key point is that larger
droplets carry a much larger number of pathogens (a higher
payload), but are also more likely to deposit in the NPTB region
than the alveoli (cf. Figure 3B). The primary role of evaporation,
then, is to shrink the larger droplets to a size that has a higher
probability of traversing deep into the airway and depositing
within the lower respiratory tract of the test animal. Under many
conditions, however, the evaporation proceeds so rapidly that all
drops reach their terminal size within a very short distance from
the source. This effect can be seen in Figure 4D, E and J, K, where
the transmission probability contours barely change despite a 37%
reduction in the evaporation rate. Only at very low evaporation
rates, such as at 99% RH (Figure 4F, L), do the droplets fail to
reach a size appropriate for deposition in the alveoli within a
sufficiently short distance. Although the droplets eventually reach
their terminal size even at high humidities, they are so far
downstream that the turbulent dispersion has diluted the effective
droplet concentration to negligible values.
The model is compared directly to the experimental measure-
ments by Lowen et al. in Figure 5. Note that one of the main
implications of the model is that simple linear regressions of
transmission probability versus either temperature or humidity will
not yield strong correlations, since the temperature serves as a
confounding variable for humidity. Instead, both temperature and
humidity should be considered simultaneously. Figure 5 presents
the predicted probability of transmission at a fixed distance
downstream as a function of relative humidity and absolute
humidity for varied temperatures for the alveolar and NPTB
deposition models. The experimental measurements by Lowen et
al. are superimposed as discrete points. The model qualitatively
captures two important trends. First, the predicted probability of
transmission is close to zero at 30uC regardless of humidity, in
accord with the experimental observations, for both deposition
models. Second, the model predicts the highest probability of
transmission at 5uC and lower humidities for the alveolar model
(Figure 5A–B). At very high relative humidities, probability drops
off rapidly at all temperatures as the evaporative process is slowed.
For the NPTB model, there is a slight increase in probability at
very high relative humidities, as the likelihood of deposition here
increases with size.
One of the key implications of the model is that the probability
of infection depends very sensitively on both the viral growth
dynamics within the inoculated animals and the physical details of
the airflow. This former effect is explored in Figure 6A, which
shows the probability of transmission for varied np
drop, max and tpeak
(all other variables held constant). As noted in the introduction, the
transmission probability depends directly on the integral with
respect to time of the viral concentration within the inoculated
animal; the time integral itself depends on np
drop, max and tpeak. Two
trends are apparent in Figure 6A. First, the likelihood of infection
is increased for higher values of np
drop, max, as expected intuitively.
Figure 6A makes clear, however, that a factor of 10 reduction in
the peak pathogen concentration can significantly reduce the
probability of transmission; note that the probability drops from
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Figure 4. Probability of transmission at different positions. Contour plots of the probability of transmission as a function of position
downstream from an infected animal located at the origin for the pulmonary (A–F) and NPTB (G–L) deposition efficiencies. Red denotes high
probability of transmission, blue denotes low probability. (A–C, G–I) Fixed relative humidity and varying temperature. (D–F, J–L) Fixed temperature
and varying relative humidity. Note that the transmission probability depends strongly on temperature but more weakly on humidity.
doi:10.1371/journal.pone.0037088.g004
Figure 5. Effect of ambient humidity and temperature on transmission probability. The predicted probability of transmission at varied
temperatures versus (A, C) relative humidity and (B, D) absolute humidity for the pulmonary (A–B) and NPTB (C–D) deposition efficiencies at 10 cm
and 30 cm downstream, respectively. The experimental observations by Lowen et al. [4,5] are shown as discrete points. Blue circles: T = 5uC; gray
triangles: T = 20uC; red squares: T = 30uC.
doi:10.1371/journal.pone.0037088.g005
Breath Plume Model for Disease Transmission
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37088
nearly 100% to about 10% for a reduction from lognp
drop, max = 8.5
to 7.5. The effect of varied tpeak is more subtle. At low values of tpeak,
the onset of the decay period occurs prior to exposure of the naı¨ve
animal, and the peak concentrations are missed. At high values of
tpeak, the onset of the decay period occurs after the experiment is
finished, but kg is lower, again decreasing the total amount of
pathogen to which the naive guinea pig is exposed. For
intermediate values of tpeak, the probability increases weakly with
increased tpeak.
The effect of the airflow parameters on the transmission
probability (for fixed viral growth parameters) is shown in
Figure 6B. For animals located along y= 0, increasing the
turbulent dispersivity slightly causes significant reductions in the
transmission probability. Physically, this decrease reflects the
increased dispersion of droplets in the orthogonal direction; in
other words, increasing the turbulence spreads the droplets further
away from the test animal, decreasing the number ultimately
inhaled. Similarly, increasing the mean airflow velocity decreases
the transmission probability because the droplets blow by so
quickly that the concentration at any point is lowered (Equation 4).
We note that limited data exists to corroborate the effect of
airspeed predicted here; specifically, the transmission probability
was observed to decrease with increased airflow velocity in an
early study with mice [42]. This result and Figure 6B demonstrate
that accurate measurements of the airflow velocity and degree of
turbulence are crucial in airborne transmission experiments, since
small changes in the nature of the airflow might account for
differences in transmission probability that would otherwise be
erroneously attributed to differences in biological infectiousness.
Finally, we consider the effect of x, the ratio of the nasal titer to
bronchial titer (cf. Equation 2). Lowen et al. predominantly studied
a strain of H3N2, influenza A/Panama/2007/99 (Pan99) [3–5].
In a more recent paper, Mubareka et al. also looked at airborne
transmission with a strain of H1N1, influenza A/Texas/36/1991
(Tx91). The viral kinetics of guinea pigs intranasally inoculated
with Tx91 and rPan99, a recombinant form of Pan99, are shown
in Figure 7 [6]. The viral kinetics within guinea pigs inoculated
with each strain follow the standard exponential growth and decay
patterns, but the growth phase in the Tx91 inoculated guinea pig
takes slightly longer. Figure 8 shows that the infectious zone for the
Tx91 infected guinea pig (Figure 8B) is slightly larger than that of
the rPan99 strain (Figure 8A) when x for both strains is assumed to
be 1. However, Mubareka et al. reported higher transmissibility for
rPan99 than for Tx91 in airborne experiments; 75% (3/4) of
guinea pigs became infected with rPan99, while only 25% (1/4)
contracted Tx91 [6]. Mubareka et al. measured the airborne titers
of each strain using an aerosol sampling technique, and found that
the maximum concentration of rPan99 was nearly an order of
magnitude greater than the largest measurement of Tx91 [6].
We emphasize that the above observation supports the central
assumption of the model presented here: the higher the airborne
concentration of pathogens, the higher the probability of
transmission. It also highlights, however, the necessity of
measuring the pathogen concentration within the respiratory fluid
at the most likely point of origin of the expiratory aerosols, i.e., the
bronchioles. Specifically, Mubareka et al.’s findings [6] suggest that
the bronchial concentration of Tx91 virus and the corresponding
concentration in the exhaled droplets are lower compared to
rPan99. Since the nasal titers for guinea pigs infected with the two
strains were roughly equivalent, the observations suggest that the
proportionality constant x is smaller for Tx91 infected guinea pigs
than for rPan99 infected animals. Indeed, our model calculations
suggest that a small change in x yields a significant change in
transmission probability: a decrease in x from 1 to 0.135 yields a
decrease in transmission probability from 88% to 25% (Figure 8B–
C). Note that a factor of 6 difference between nasal and bronchial
concentration is quite possible, given for example the observations
for virus growth in the nose and lungs reported by Tang et al. [23]
Since x has not yet been measured experimentally, it serves here as
a fitting parameter; the key result however is that plausible values
of x yield results that are consistent with the observed effect of
different viral strains. In the context of the experiments of
Mubareka et al., varying x illustrates the difference in airborne
transmissibility of different strains of influenza A. The model can
be also used to show that different strains can have the same x
value and thus have similar transmission patterns, as was the case
Figure 6. Sensitivity analysis of viral kinetics and airflow
parameters for NPTB deposition efficiency 30 cm downstream.
(A) Contour plot of transmission probability as a function of np
drop, max
and tpeak. The animals are assumed to be brought into contact one day
post-inoculation and removed seven days later. (B) Contour plot of
transmission probability as a function of the turbulent dispersivity
coefficients iy, iz (assumed equal) and mean airflow velocity U. Small
changes in either the degree of turbulence or the flow velocity yield
large changes in the transmission probability.
doi:10.1371/journal.pone.0037088.g006
Figure 7. Guinea pig viral growth kinetics of rPan99 and Tx91.
The measurements by Mubareka et al. [6] of the influenza concentration
observed in nasal titers obtained from inoculated guinea pigs infected
with rPan99 and Tx91. Black circles: rPan99; purple squares: Tx91.
Dashed lines are fits to a numerical model for influenza viral dynamics
[18].
doi:10.1371/journal.pone.0037088.g007
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in the recent experiments of Steel et al. [43] (Text S4, Figures S2
and S3).
Model Implications
The theoretical framework developed here suggests a number of
future experiments. First, assessments of transmission probability
will greatly benefit from higher measurement frequency during the
growth stage of the viral dynamics. The earliest measurements by
Lowen et al. of the viral concentration did not occur until 48 hours
post-inoculation, so the amount of pathogen the animals are
exposed to during the first 24 hours must be inferred by numerical
modeling. Experimental measurements at earlier times near tpeak
are crucial, as well as careful determination of the droplet
expulsion rate and droplet composition, including the number of
pathogens per droplet. Other key infective parameters, such as the
minimum infectious dose, should be assessed. Moreover, exhaled
breath condensate studies from guinea pigs infected with each
virus will be essential to gauge the actual number of exhaled
pathogens as a function of time following inoculation. Second,
both the experiments and the model clearly indicate that the
airflow greatly affects the transmission probability, but to date no
experimental characterization of the background airflow has been
performed. The cages and the guinea pigs themselves could also
alter the airflow, as they provide physical barriers within the
chamber; flow profiles around physical obstructions should be
experimentally measured to gauge their impact on transmission.
Third, variability in the guinea pig breathing rate should be
characterized. Minute ventilation, the amount breathed by the
animal per minute, has a strong temperature dependence [44], but
to our knowledge, has not been investigated for guinea pigs. This
relationship is important for determining both the number of
respiratory droplets released into the air (q) and the amount of air
inhaled by the test animal (B). The effect of ambient humidity
should likewise be measured, since humidity also affects the
breathing rate [44]. Similarly, the activity level of the guinea pig
will cause changes in its breathing patterns; respiration experi-
ments should be conducted in a number of scenarios, with animals
at rest and in motion.
Fourth, the evaporation model used here should be tested
rigorously with mucosa from infected animals. The nonvolatile
materials in the expelled respiratory aerosols will depress the vapor
pressure of the water, thus slowing the evaporation process and
altering the probability distribution. The aerosols may also form a
permanent solid structure prior to releasing all of their water
[30,31]. At higher relative humidities, the hygroscopic nature of
the salt components may cause the droplets to increase in size. At
relative humidities greater than the deliquescence relative humid-
ity, aerosols will begin to grow through the acquisition of water
from their surroundings [32]. Conversely, at the efflorescence
relative humidity, aerosols will suddenly expel their water content
and crystallize. The value of the efflorescence and deliquescence
relative humidities are not known due to the droplets’ complex
and varying chemical compositions, so the range of relative
humidities during which evaporation will occur versus growth or
crystallization has not been identified.
Fifth, the effect of humidity on the viral growth kinetics within
the animal should be investigated. As shown in Figure 4, the model
predicts an increase in NPTB infection at high humidity, whereas
experimentally a decrease in transmission is observed. An
important caveat is that the model presented here only considers
the effect of ambient humidity on the evaporation rate of the
droplets. If humidity affects anything else – such as the viral
growth kinetics – then the model must be extended to include
those effects. Additional experimental work should be performed
at constant temperature but varied humidity to directly assess
whether humidity modulates the viral growth kinetics or some
other key parameter in the model (e.g., deposition efficiency or
breathing rate).
Although we focus here on influenza A, the theoretical
framework is applicable to any sort of airborne disease carried
by expiratory droplets (e.g., pneumonia, measles, smallpox, or the
common cold). The model could be expanded to account for
increased droplet concentration created through symptoms such as
sneezing and coughing, which typically generate a greater number
of droplets with a significantly larger average size compared to
those generated by regular breathing [45, Text S3]. Different
deposition models could be employed, especially when looking at
infection in different species. Likewise, since the animals are
typically mobile in their cages, information about the dynamics of
their relative distances from each other could be included.
Furthermore, the model presented here assumes air is not
recirculated through the test chamber. Since national standards
for animal care have a high fresh air requirement, it is likely the
recirculated air is highly diluted. If a substantial amount of air is
recirculated, however, then details about the frequency with which
old air is removed and fresh air is introduced must be included, as
Figure 8. Probability of transmission at different positions for
rPan99 and Tx91 experiments. Contour plot of transmission
probability in (A) rPan99 experiment with x= 1, (B) Tx91 experiment
with x=1, and (C) Tx91 experiment with x= .135 using the NPTB
deposition efficiency. At x<7 cm, transmission probabilities match the
findings of Mubareka et al. [6] (A, C).
doi:10.1371/journal.pone.0037088.g008
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well as the filtration coefficient, which quantifies the percent of
droplets removed from the air per pass through the chamber (i.e.,
by contact with any dust filters or airflow equipment). If a
sufficiently large amount of air is being recirculated with minimal
filtration, virus survivability could also become an important
factor.
As a final comment, the basic framework of the model could be
extended to case of airborne transmission between humans, but
several challenges must be overcome. First, the droplet expiration
associated with talking, coughing, and sneezing must be incorpo-
rated [46,47]; these processes all generate a large number of
expiratory droplets, which contain infective pathogens [48–52]. A
more general model would also need to be adjusted to account for
differences in immunological response, including pre-existing
immunities. Most importantly, humans tend to be much more
mobile than animals in cages, so even in situations where humans
are located in a time-invariant background airflow (e.g., the air-
conditioning in an office or classroom environment), information
about the dynamics of the relative distance between infected and
uninfected individuals would need to be explicitly included. The
theory presented here serves as a framework for considering these
more complicated effects.
Supporting Information
Figure S1 Viral kinetics and expelled particle size
distribution. (A) The measurements by Lowen et al. [4,5] of
the influenza concentration observed in nasal titers obtained from
inoculated guinea pigs maintained at different temperatures. Blue
circles: T = 5uC; gray triangles: T = 20uC. Dashed lines are fits to a
numerical model for influenza viral dynamics [18]; solid lines are
analytical estimates given by Equation 1. (B) Size distribution of
respiratory particles from normally paced closed mouth respiration
from ferrets infected with influenza A/Panama/2007/99 (Pan99).
Reproduced from Gustin et al. [40].
(TIF)
Figure S2 Guinea pig viral growth kinetics of Pan99 and
Tx91. The measurements by Steel et al. [43] of the influenza
concentration observed in nasal titers obtained from inoculated
guinea pigs infected with Pan99 and NL09 housed at (A) 20uC and
(B) 30uC. Black circles: Pan99; green squares: NL09. Dashed lines
are fits to a numerical model for influenza viral dynamics [18].
(TIF)
Figure S3 Probability of transmission at different
positions for Pan99 and NL09 experiments. Contour plot
of transmission probability for ambient conditions used in the
experiments of Steel et al. [43] (A–B) T = 20uC, RH = 65%. (C–D)
T = 20uC, RH = 80%. (E–F) T = 30uC, RH = 20%. (G–H)
T = 30uC, RH = 80%. Temperature and humidity trends for both
deposition models were consistent, so results are shown simply for
the NPTB deposition model. For both strains, x= 1. Infection
rates reported by Steel et al. [43] are listed above each plot.
(TIF)
Table S1 Model Parameters.
(PDF)
Table S2 Viral Kinetics Model Parameters.
(PDF)
Text S1 Viral Kinetics Model.
(DOC)
Text S2 Justification for Neglecting Gravity.
(DOC)
Text S3 Respiratory Particle Size Distribution.
(DOC)
Test S4 Comparison with Steel et al. experiments.
(DOC)
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